The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
H.R. 9923·119th Congress·Introduced Jul 23, 2026

Biotechnology Diplomacy and Expertise Enhancement Act of 2026

IntroducedInternational AffairsSubstantive
View bill text
Sponsor
Del. Moylan, James C. [R-GU-At Large]
Committees
Foreign Affairs Committee (primary)
Last action
Jul 23, 2026

Bottom line

The bill aims to bolster U.S. diplomatic capacity in biotechnology by creating a specialized cadre of foreign service officers focused on international biotech engagement, security, and innovation.

What it actually does

This bill, the "Biotechnology Diplomacy and Expertise Enhancement Act of 2026," mandates the expansion of the Department of State's Regional Technology Officer (RTO) Program to include biotechnology experts and specialized training in biotechnology for all RTOs. It directs the Secretary of State to develop strategies for recruitment, training, and deployment of these officers to advance U.S. leadership and foreign policy objectives in biotechnology. The bill also provides an exemption from hiring freezes for these critical personnel.

Proponents argue

Supporters argue that this bill is crucial for maintaining U.S. leadership in the rapidly evolving field of biotechnology. They contend that specialized biotechnology RTOs will enable the U.S. to effectively engage in international forums, shape global policies, promote democratic values, and protect national security interests related to biotechnology and biomanufacturing. Proponents believe that proactive diplomacy in this sector is essential to counter adversarial influence and ensure responsible technological development.

Opponents contend

Critics might argue that while the goals are laudable, creating a new specialized cadre within the State Department could lead to bureaucratic bloat or divert resources from other critical diplomatic priorities. Some may question the effectiveness of a dedicated RTO program versus integrating biotechnology expertise more broadly across existing diplomatic roles. Concerns could also be raised about the potential for mission creep or the difficulty of rapidly training officers to keep pace with fast-changing biotechnologies.

The bill is concise and straightforward, allowing for a quick read and easy comprehension of its core objectives and mechanisms.

Section 2, amending 22 U.S.C. 10305(d)

Mandate for Biotechnology Expertise in Regional Technology Officer Program

prominently featuredstraightforward

This section requires the Secretary of State to expand the existing Regional Technology Officer (RTO) Program to include experts specifically in biotechnology. It mandates that all RTOs, both current and new, receive specialized training in biotechnology and emerging biotechnologies. The goal is to position these officers as key diplomatic assets for the U.S. in international collaboration, national security, innovation, and policy development within the biotechnology sector.

GroupImpactMechanismScale
GroupDepartment of StateImpactIncreased staffing and training requirements, shift in programmatic focus.MechanismNew hiring directives and mandatory training programs.ScaleDepartment-wide impact on a specific program.
GroupU.S. biotechnology sectorImpactEnhanced international advocacy and collaboration opportunities.MechanismDiplomatic efforts to promote U.S. leadership and secure partnerships.ScaleNational and international.

Supporters argue

Supporters argue this provision is vital for ensuring the U.S. has the diplomatic capacity to navigate complex global biotechnology issues, protect its interests, and promote responsible innovation. They believe it directly addresses a gap in current diplomatic expertise.

Critics contend

Critics might suggest that while the intent is good, the implementation could be challenging, potentially leading to a diluted focus if not managed carefully, or that existing personnel could be cross-trained without a full program expansion.

Tradeoffs

The tension lies between the urgent need for specialized expertise in a critical emerging field and the potential for creating new bureaucratic structures or diverting resources from other diplomatic priorities.

Section 2, amending 22 U.S.C. 10305(d)(2) and (3)

Defining Objectives and Curriculum for Biotechnology RTOs

prominently featuredstraightforward

This part of the bill outlines specific goals for the biotechnology-trained RTOs, including promoting U.S. leadership, advancing democratic values, shaping diplomatic agreements, facilitating foreign policy objectives, and ensuring responsible use and secure transfer of biotechnologies. It also details the required training curriculum, covering topics like gene editing, synthetic biology, biosecurity, ethical considerations, international regulations, and diplomatic engagement strategies specific to biotechnology.

Section 3

Strategic Implementation and Oversight

mentioned in summarystraightforward

This section directs the Secretary of State to develop a comprehensive strategy for recruiting and hiring technical experts for the RTO Program, specifically expanding it to include biotechnology experts in fiscal year 2026. It also mandates an implementation report to Congress within 180 days, detailing these strategies, and requires annual reports on the program's progress, including the number of trained officers, their assignments, and the outcomes of diplomatic efforts related to biotechnology.

Section 4

Exemption from Hiring Freezes for Biotechnology RTOs

prominently featuredstraightforward

This provision explicitly exempts the hiring of personnel necessary to implement this Act, including biotechnology-focused Regional Technology Officers, from any existing or future hiring freeze or personnel limitation within the Department of State. It also prioritizes the recruitment, training, and overseas deployment of RTOs with expertise in biotechnology, biosecurity, and emerging life science technologies.

FOUND

The bill encourages the Secretary of State to collaborate with various stakeholders (federal agencies, private sector, academia) in developing training programs and to ensure continuing education for Regional Technology Officers on the latest biotechnology advances.

Section 2, amending 22 U.S.C. 10305(d)(4) and (5)

Why it matters:This is standard legislative practice to provide flexibility for implementation while still signaling congressional intent for best practices. It's not necessarily evasive, but it does allow for discretion.

Case for: Proponents argue that this flexibility allows the Department of State to adapt its training and partnerships as the biotechnology landscape evolves, fostering innovation and relevance without being overly prescriptive.

Case against: Critics might contend that without a stronger mandate, these crucial aspects of program development and officer readiness could be deprioritized, leading to less effective training and outdated expertise over time.

Estimated impact: Qualitative impact on the quality and adaptability of the RTO program; no direct fiscal impact.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Buried treasure
  • Follow the money
  • Critical analysis
  • Questions to ask
Ask Ledger AI about this